Figure 3.
Characteristics of nanoparticles. (A) Drug release profiles of (i) BSA and (ii) coumarin-6 from PLGA, UPE and BPLP-PLGA NPs show UPE nanoparticles displaying slower and more sustained drug release. (B) Degradation profiles of these nanoparticles show weight loss of the NPs with time indicating biodegradability.